These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 37067947)

  • 1. Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients.
    Noviello M; Lorentino F; Xue E; Racca S; Furnari G; Valtolina V; Campodonico E; Dvir R; Lupo-Stanghellini MT; Giglio F; Piemontese S; Clerici D; Oltolini C; Tassi E; Beretta V; Farina F; Mannina D; Ardemagni A; Vago L; Bernardi M; Corti C; Peccatori J; Clementi M; Ciceri F; Bonini C; Greco R
    Blood Adv; 2023 Sep; 7(18):5446-5457. PubMed ID: 37067947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HHV-6 infection after allogeneic hematopoietic stem cell transplantation: From chromosomal integration to viral co-infections and T-cell reconstitution patterns.
    Quintela A; Escuret V; Roux S; Bonnafous P; Gilis L; Barraco F; Labussière-Wallet H; Duscastelle-Leprêtre S; Nicolini FE; Thomas X; Chidiac C; Ferry T; Frobert E; Morisset S; Poitevin-Later F; Monneret G; Michallet M; Ader F;
    J Infect; 2016 Feb; 72(2):214-22. PubMed ID: 26518057
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human herpesvirus-6 in hematopoietic stem cell transplant recipients: a prospective cohort study in Egypt.
    Raouf MME; Ouf NM; Elsorady MAS; Ghoneim FM
    Virol J; 2023 Feb; 20(1):20. PubMed ID: 36739398
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human CD134 (OX40) expressed on T cells plays a key role for human herpesvirus 6B replication after allogeneic hematopoietic stem cell transplantation.
    Nagamata S; Nagasaka M; Kawabata A; Kishimoto K; Hasegawa D; Kosaka Y; Mori T; Morioka I; Nishimura N; Iijima K; Yamada H; Kawamoto S; Yakushijin K; Matsuoka H; Mori Y
    J Clin Virol; 2018 May; 102():50-55. PubMed ID: 29494951
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral reactivations following hematopoietic stem cell transplantation in pediatric patients - A single center 11-year analysis.
    Düver F; Weißbrich B; Eyrich M; Wölfl M; Schlegel PG; Wiegering V
    PLoS One; 2020; 15(2):e0228451. PubMed ID: 32017805
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High human herpesvirus 6 viral load in pediatric allogeneic hematopoietic stem cell transplant patients is associated with detection in end organs and high mortality.
    Winestone LE; Punn R; Tamaresis JS; Buckingham J; Pinsky BA; Waggoner JJ; Kharbanda S
    Pediatr Transplant; 2018 Mar; 22(2):. PubMed ID: 29181879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human herpesvirus 6 reactivation on the 30th day after allogeneic hematopoietic stem cell transplantation can predict grade 2-4 acute graft-versus-host disease.
    Gotoh M; Yoshizawa S; Katagiri S; Suguro T; Asano M; Kitahara T; Akahane D; Okabe S; Tauchi T; Ito Y; Ohyashiki K
    Transpl Infect Dis; 2014 Jun; 16(3):440-9. PubMed ID: 24810656
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Prevalence of human herpesvirus-6 in allogeneic hematopoietic stem cell transplant recipients in correlation with cytomegalovirus infection].
    Wang LR; Dong LJ; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1204-9. PubMed ID: 17204195
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Once-Daily Foscarnet Is Effective for Human Herpesvirus 6 Reactivation after Hematopoietic Stem Cell Transplantation.
    Vittayawacharin P; E'Leimat G; Lee BJ; Griffin S; Doh J; Nam H; Blodget E; Jeyakumar D; Kongtim P; Ciurea SO
    Transplant Cell Ther; 2023 Jun; 29(6):397.e1-397.e6. PubMed ID: 36878429
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Human herpes virus 6 plasma DNA positivity after hematopoietic stem cell transplantation in children: an important risk factor for clinical outcome.
    de Pagter PJ; Schuurman R; Visscher H; de Vos M; Bierings M; van Loon AM; Uiterwaal CS; van Baarle D; Sanders EA; Boelens J
    Biol Blood Marrow Transplant; 2008 Jul; 14(7):831-9. PubMed ID: 18541204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human Herpesvirus 6 Reactivation Evaluated by Digital Polymerase Chain Reaction and Its Association With Dynamics of CD134-Positive T Cells After Allogeneic Hematopoietic Stem Cell Transplantation.
    Nakayama H; Yamazaki R; Kato J; Koda Y; Sakurai M; Abe R; Watanuki S; Sumiya C; Shiroshita K; Fujita S; Yamaguchi K; Okamoto S; Mori T
    J Infect Dis; 2019 Aug; 220(6):1001-1007. PubMed ID: 31063196
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human herpesvirus-6B infection in pediatric allogenic hematopoietic stem cell transplant patients: Risk factors and encephalitis.
    Miura H; Kawamura Y; Hattori F; Tanaka M; Kudo K; Ihira M; Yatsuya H; Takahashi Y; Kojima S; Sakaguchi H; Yoshida N; Hama A; Yoshikawa T
    Transpl Infect Dis; 2020 Feb; 22(1):e13203. PubMed ID: 31650671
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of Human Herpesvirus-6 Reactivation on Outcomes of Allogeneic Hematopoietic Stem Cell Transplantation.
    Aoki J; Numata A; Yamamoto E; Fujii E; Tanaka M; Kanamori H
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2017-22. PubMed ID: 26226409
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of human cytomegalovirus-specific CD8+ T-cells in allogeneic haematopoietic stem cell transplant recipients using pentamer and interferon-γ-enzyme-linked immunospot assays.
    Liu A; Ma Y; Wu W; Chen X; Huang Y; Hu J; Liang H; Wang H; Yang R; Fan J
    J Clin Virol; 2013 Oct; 58(2):427-31. PubMed ID: 23910932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Human herpesvirus 7 infection in patients after allogeneic hematopoietic stem cell transplantation].
    Wang LR; Dong LJ; Lu DP
    Zhonghua Yi Xue Za Zhi; 2007 Aug; 87(30):2113-6. PubMed ID: 17988530
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human herpesvirus 6 reactivation in unmanipulated haploidentical hematopoietic stem cell transplantation predicts the occurrence of grade II to IV acute graft-versus-host disease.
    Han TT; Zhang YN; Sun YQ; Kong J; Wang FR; Wang ZD; Cheng YF; Yan CH; Wang Y; Xu LP; Zhang XH; Liu KY; Huang XJ; Zhao XS
    Transpl Infect Dis; 2021 Jun; 23(3):e13544. PubMed ID: 33326670
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The impact of human herpesvirus 6B reactivation on early complications following allogeneic hematopoietic stem cell transplantation.
    Wang LR; Dong LJ; Zhang MJ; Lu DP
    Biol Blood Marrow Transplant; 2006 Oct; 12(10):1031-7. PubMed ID: 17067909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human herpesvirus-6 encephalopathy after hematopoietic stem cell transplantation and class I human leukocyte antigen.
    Yamamoto W; Ogusa E; Matsumoto K; Maruta A; Ishigatsubo Y; Kanamori H
    Clin Transplant; 2014 May; 28(5):540-5. PubMed ID: 24579822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of Specific Antibody Level on Human Herpesvirus 6 Reactivation after Allogeneic Stem Cell Transplantation.
    Nakayama H; Yamazaki R; Kato J; Koda Y; Sakurai M; Mori T
    Transplant Cell Ther; 2021 Feb; 27(2):174.e1-174.e5. PubMed ID: 33830031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human herpesvirus 6 encephalitis in patients administered mycophenolate mofetil as prophylaxis for graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Inui Y; Yakushijin K; Okamura A; Tanaka Y; Shinzato I; Nomura T; Ichikawa H; Mizutani Y; Kitao A; Kurata K; Kakiuchi S; Miyata Y; Sanada Y; Kitagawa K; Uryu K; Kawamoto S; Yamamoto K; Matsuoka H; Murayama T; Ito M; Minami H
    Transpl Infect Dis; 2019 Feb; 21(1):e13024. PubMed ID: 30414316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.